Research Article | Open Access
Yong-Hyeon Lee, Dong-Hyun Seo, Ji-Hyung Park, Kazuya Kabayama, Joerg Opitz, Kwang Ho Lee, Han-Sung Kim, Tack-Joong Kim, "Effect of Oenothera odorata Root Extract on Microgravity and Disuse-Induced Muscle Atrophy", Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 130513, 9 pages, 2015. https://doi.org/10.1155/2015/130513
Effect of Oenothera odorata Root Extract on Microgravity and Disuse-Induced Muscle Atrophy
Muscle atrophy, a reduction of muscle mass, strength, and volume, results from reduced muscle use and plays a key role in various muscular diseases. In the microgravity environment of space especially, muscle atrophy is induced by muscle inactivity. Exposure to microgravity induces muscle atrophy through several biological effects, including associations with reactive oxygen species (ROS). This study used 3D-clinostat to investigate muscle atrophy caused by oxidative stress in vitro, and sciatic denervation was used to investigate muscle atrophy in vivo. We assessed the effect of Oenothera odorata root extract (EVP) on muscle atrophy. EVP helped recover cell viability in C2C12 myoblasts exposed to microgravity for 24 h and delayed muscle atrophy in sciatic denervated mice. However, the expressions of HSP70, SOD1, and ceramide in microgravity-exposed C2C12 myoblasts and in sciatic denervated mice were either decreased or completely inhibited. These results suggested that EVP can be expected to have a positive effect on muscle atrophy by disuse and microgravity. In addition, EVP helped characterize the antioxidant function in muscle atrophy.
Skeletal muscle atrophy can be induced by muscle disuse stemming from chronic inactivity (e.g., immobilization, bed rest, mechanical unloading, and spaceflight). These results can be loss of muscle mass, strength, and volume . A recent study focused on the role of reactive oxygen species (ROS) and several complex biological effectors in causing and defining skeletal muscle atrophy . ROS play an important regulatory role in skeletal muscle atrophy: during periods of muscle disuse ROS expression is increased by redox system disturbance . Proteolysis involving the redox system evidently contributes to degradation of skeletal muscle protein during periods of disuse . Space flight can increase free radical formation, thereby increasing the level of oxidative stress . This effect is more pronounced in space flights of long duration . An improvement in the balance of the antioxidant defense system will lessen the severity of oxidative stress induced by space flight . Because muscle atrophy is caused by various factors, it is difficult to test it using the human. Hindlimb suspension and sciatic denervation are done with research animal models which can imitate a variety of conditions that induce human skeletal muscle atrophy , but it is still hard to simulate the space environment. Thus, the three-dimensional-clinostat (3D-clinostat) was developed to simulate microgravity for biological research [8, 9].
Several cell signals may regulate the oxidative stress associated with muscle atrophy. Heat shock proteins (HSPs), whose major function is to provide a molecular protein chaperone to regulate the assembly, rearrangement, and folding of proteins [10–13], have been known to protect cells against various stress-inducible apoptotic factors, including heat shock, tumor necrosis factor, starvation, and oxidative stress . More importantly, HSP70 has been known as a promising molecule for regulation of the oxidative stress which induces apoptosis. A recent study has confirmed that HSP70 expression regulates oxidative stress . Therefore, an increase in the expression of HSP70 can have a positive effect in muscle atrophy. Also, ceramides have been known as sphingolipid mediators in stress-inducible apoptosis . Various stressor-factors leading to apoptosis have been reported to increase ceramide levels in several cell types, including myoblasts [17–22]. HSP70 may have antiapoptotic effects upstream of ceramide-induced caspases . Additionally, Cu-Zn superoxide dismutase (SOD1), an antioxidant enzyme which catalyzes the dismutation of superoxide, is an important part of the antioxidant system for cells exposed to ROS. Absence of SOD1 leads to induced skeletal muscle atrophy by elevated oxidative stress .
In this study we confirmed that several cellular signal expression levels, including HSP70, ceramide, and SOD1 are affected by Oenothera odorata root extracts (EVP) in situations of oxidative stress induced by microgravity and disuse muscle atrophy. The oil of O. odorata seeds has previously been shown to have several beneficial effects on human health including antidiabetic, anti-inflammatory, and antipremenstrual activity [25, 26] but so far antioxidant effects of this plant have been unclear.
2. Materials and Methods
Penicillin-streptomycin was obtained from Lonza (Walkersville, MD, USA). An EZ-Cytox cell viability kit was purchased from Daeil Lab (Seoul, Korea). Antibody against HSP70 was purchased from Enzo Life Sciences, AG (Lausen, Switzerland). SOD1 and β-actin antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). N-acetyl-L-cysteine (NAC) and ortho-phthalaldehyde (OPA) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Sphingomyelin, dihydrosphingomyelin, ceramide, and sphingolipid ceramide N-deacylase (SCDase) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). High Performance Thin Layer Chromatography (HPTLC) silica-gel plate, chloroform, and HPLC grade methanol were purchased from Merck (Darmstadt, Germany). Vectashield mounting medium with DAPI was purchased from Vector Laboratories (Burlingame, CA, USA). All other chemicals used were the highest analytical grade that is commercially available.
2.2. Preparation of Oenothera odorata Root Extract
The O. odorata plants were cultivated according to the good agricultural practices method of the Korea Rural Development Administration and were harvested during 2009 in Eumseong-gun, Korea (GPS: E 128°62′ N 36°56′). For sample preparation, the roots were extracted with ethanol three times at 25°C for three days. The extracts were filtrated through Whatman No. 1 filter paper (GE Healthcare, Buckinghamshire, UK) and combined followed by concentration using a rotary evaporator (EYELA N-1000, Japan) at 40°C. The obtained dried extracts were lyophilized and then powdered.
2.3. Cell Culture
C2C12 myoblasts were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Lonza, Walkersville, MD, USA), 100 μg/mL penicillin-streptomycin, 8 mM N-(2-hydroxyelthyl) piperazine-N′-2-ethanesulfonic acid (HEPES), and 2 mM L-glutamine. C2C12 myoblasts were maintained at 37°C in a humidified 5% CO2 incubator.
A 3D-clinostat was used to simulate reduced gravity for gravity sensitive cell . The 3D-clinostat was designed to fit the incubator. The size of the center plates was 160 mm by 106 mm. To operate the 3D-clinostat, two motors were used. The instrument could rotate linearly whose direction is clockwise (CW) and counter clockwise (CCW) and rotate at 2 rpm.
2.5. Animal Experiments
Male C57/BL6 mice (4-week-old) were purchased from Orient Bio (Gangneung, Korea) and were housed in wired cages with temperature 20–22°C and in 40–50% humidity. The Institutional Animal Care and Use Committee (IACUC, YWC-130204-1) at Yonsei University (Wonju, Korea) approved the protocol for this study. An attempt was made to minimize the pain of the animals. The sciatic nerve in the right leg of each mouse was surgically removed fragmentally to induce immobilization, and muscle atrophy occurred in the gastrocnemius muscle (GM) and soleus muscle (SM). These mice had induced muscle atrophy by sciatic denervation for 7 days. Then EVP (1-2 mg/kg) was injected by intramuscular injection 10 times over a 2-week period. The mice were sacrificed 21 days after sciatic denervation.
2.6. Microcomputed Tomography
Microcomputed tomography (micro-CT) images of the muscle in the tibia of each mouse () were acquired 21 days after the induced muscle atrophy, using the micro-CT (SkyScan 1076, Bruker, Germany) at a resolution of 35 μm, with the following parameters: 100 kV, 100 mA, 790 ms, and a rotation step of 1.2°. The mice were under anesthesia during the scanning. The beam-hardening errors were corrected to improve the quality of the micro-CT images by flat-field correction before scanning and beam-hardening correction during reconstruction. For the evaluation of muscle volume, 3D models of the tibia were reconstructed using CT-Analyzer 1.11 (CT-An 1.11, Bruker, Germany).
2.7. Cell Viability and Cytotoxicity
Cell viability was assessed with an EZ-Cytox cell viability kit following the manufacturer’s instructions. Briefly, C2C12 myoblasts ( cells/well) were seeded into 96-well culture plates and incubated overnight in DMEM containing 10% (v/v) FBS at 37°C. When C2C12 myoblasts reached 70% confluence, the medium was replaced with serum-free DMEM containing various concentrations of EVP (0–50 μg/mL) for 24 hr. To expose the microgravity, the medium was replaced with DMEM containing 10% (v/v) FBS. Microgravity was induced by 3D-clinostat for 24 hr. EZ-Cytox kit reagents were added to the medium, the C2C12 myoblasts were incubated for 1 hr, and then the optical density was determined at 450 nm using a microplate reader (BioTek Instruments Inc., Winooski, VT, USA).
2.8. Immunoblot Analysis
C2C12 myoblasts (2 × 105 cells/well) were seeded into 6-well culture plates and incubated overnight in DMEM containing 10% (v/v) FBS at 37°C. Then, C2C12 myoblasts were cultured for 24 hr with or without EVP (50 μg/mL) in serum-free DMEM. To expose the microgravity, the medium was replaced with DMEM containing 10% (v/v) FBS. Microgravity was induced by 3D-clinostat for 0–24 hr. Atrophy of GM and SM was induced by sciatic denervation with or without EVP (1-2 mg/kg) injection. Protein lysate was extracted using the PRO-PREP protein extraction kit (iNtRON, Sungnam-Si, Korea) following the manufacturer’s instructions. The whole lysates were analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10–15% polyacrylamide gels. The proteins were transferred to PVDF membrane (Bio-Rad, Hercules, CA, USA). The membranes were blocked overnight at 4°C in Tris-buffered saline containing 0.1% Tween-20 (TBS/T) and 5% skimmed milk powder and then incubated with each primary antibody. Blots were washed with TBS/T and incubated with each horseradish peroxidase-conjugated secondary antibody. Proteins were detected using an enhanced chemiluminescence (ECL) detection reagent for immunoblot analysis (GE Healthcare, Buckinghamshire, UK).
2.9. High Performance Liquid Chromatography (HPLC)
C2C12 myoblasts (2 × 105 cells/well) were seeded into 6-well culture plates and incubated overnight in DMEM containing 10% (v/v) FBS at 37°C. Then, C2C12 myoblasts were cultured for 24 hr with or without EVP (50 μg/mL) in serum-free DMEM. To expose the microgravity, the medium was replaced with DMEM containing 10% (v/v) FBS. Microgravity was induced by 3D-clinostat for 24 hr. Atrophy of GM and SM was induced by sciatic denervation with or without EVP (1-2 mg/kg) injection. C2C12 myoblasts and tissues from mice provided samples for lipid extraction. Ceramide quantification was performed according to previously described procedures  with some modifications. In brief, total lipids were extracted using chloroform/methanol/1 M NaCl solution (8 : 4 : 2.5, v/v/v) with an addition of dihydrosphingomyelin as an internal standard and dried. Then it was centrifuged at 13,000 rpm (4°C) for 10 min, and the supernatant was transferred to a clean 1.5-mL tube. The dried samples were dissolved in 30 μL of chloroform/methanol (1 : 2, v/v) and spotted on an HPTLC silica-gel plate for ceramide separation. Then ceramide was converted simultaneously to sphingosine by ceramidase in a reaction buffer (pH 7.5) containing 25 mM Tris-HCl buffer, 1% sodium chlorate, and 15% fatty acid-free bovine serum albumin. The released sphingosine from ceramide was analyzed using HPLC following ortho-phthalaldehyde derivatization.
C2C12 myoblasts (2 × 105 cells/well) were seeded on a cover glass into 6-well culture plates and incubated overnight in DMEM containing 10% (v/v) FBS at 37°C. Then, C2C12 myoblasts were cultured for 24 hr with or without EVP (50 μg/mL) in serum-free DMEM. To expose the microgravity, the medium was replaced with DMEM containing 10% (v/v) FBS. Microgravity was induced by 3D-clinostat for 24 hr. C2C12 myoblasts were fixed in 4% para-formaldehyde, 0.1% Triton-X treated for 25 min, and 3% BSA blocking for 30 min in shaking rocker. C2C12 myoblasts were incubated with antibodies against SOD1 (1 : 1000 dilution) overnight at 4°C. C2C12 myoblasts were washed three times with PBS and incubated with secondary antibodies, Alexa Fluor 488 anti-rabbit IgG (Invitrogen, Seoul, Korea), for 3 hr at 4°C. After being washed with PBS, C2C12 myoblasts were stained and mounted with DAPI-mounting media. Images were acquired with an LSM710 confocal microscope (Zeiss, Jena, Germany). During confocal microscopic observation, all the images were taken using the same settings.
2.11. Statistical Analysis
Experimental results are expressed as the mean ± SD. One-way analysis of variance (ANOVA) was followed by Tukey’s multiple comparison test using GraphPad Prism 5.0 software (GraphPad Software, Inc., San Diego, CA, USA). Values of were considered to indicate statistically significant differences.
3.1. Effect of EVP on Microgravity by 3D-Clinostat in C2C12 Myoblast
The microgravity environment of space results in muscle atrophy due to muscle disuse and inactivity. We hypothesized that EVP can have an antioxidant effect on microgravity-induced oxidative stress in C2C12 myoblasts. EVP showed no evidence of cytotoxicity within the dose range used in C2C12 myoblasts (Figure 1(a)). Microgravity (24 hr) reduced cell viability by approximately 73.31%. However, EVP (0–50 μg/mL) recovered cell viability significantly in a concentration-dependent manner (Figure 1(b)).
3.2. Effect of EVP on HSP70 Expression by Microgravity in C2C12 Myoblasts
The protective effect of HSP70 is related to the inhibition of apoptosis. Several studies have shown that HSP70 protects cells from stress induced cell death [26, 27]. We recorded the time course data of HSP70 expression patterns under a microgravity condition induced by 3D-clinostat (Figure 2(a)). Exposure to microgravity for 24 hr significantly decreased HSP70 compared to the other time groups. In addition, the expression of HSP70 increased in the group treated with EVP (50 μg/mL) (Figure 2(b)). Thus, we confirmed the relationship of microgravity and HSP70 expression. It is likely that HSP70 played a role in preventing the microgravity-induced cellular stress of C2C12 myoblasts.
3.3. Effect of EVP on Oxidative Stress by Microgravity in C2C12 Myoblasts
In this study, we used a 3D-clinostat to investigate the protective effect of EVP against microgravity-induced oxidative stress. Microgravity was induced by 3D-clinostat for 24 hr with or without EVP (50 μg/mL). SOD1, activated by cellular ROS, is antioxidant enzyme located in the cytoplasm. Using immunocytochemistry, we observed a significant increase on SOD1 expression level upon microgravity-induced oxidative stress. However, EVP (50 μg/mL) suppressed SOD1 expression level, when compared to the untreated group (Figure 3(a)). Also, we used immunoblot analysis to assess cellular protein levels. Expression of SOD1 increased significantly on oxidative stress by microgravity; however, EVP (50 μg/mL) downregulated protein expression levels (Figure 3(b)).
3.4. Effect of EVP on Ceramide Level by Microgravity in C2C12 Myoblasts
Recent several studies have suggested that induction of ceramide is caused by various stressors [29, 30]. HPLC was used to quantify ceramide upon microgravity by 3D-clinosstat in C2C12 myoblasts. Microgravity was induced by 3D-clinostat for 24 hr with or without EVP (50 μg/mL). Exposure to microgravity for 24 hr caused the 2.01-fold increase of endogenous ceramide levels. However, EVP (50 μg/mL) decreased endogenous ceramide levels by 23.61% (Figure 4).
3.5. Effects of EVP on Disuse Muscle Atrophy by Sciatic Denervation in Mice
Muscle atrophy induced by sciatic denervation was investigated with micro-CT in mice. Artificial reduction of muscular activity via sciatic denervation caused muscle atrophy. We investigated muscle volume and other factors considering the distribution of muscle. GM and SM volumes of sciatic denervated mice were lower than control mice. However, muscle volume of the EVP group was higher than the non-EVP-treated group of sciatic denervated mice (Figure 5).
3.6. Effect of EVP on HSP70 Expression by Disuse Muscle Atrophy in Mice
In this study, we investigated how muscle volume loss during disuse atrophy correlates with HSP70 expression using sciatic denervated mice. HSP70 was downregulated in denervated mice. However, HSP70 expression levels were higher in the EVP group than the non-EVP-treated group of sciatic denervated mice (Figure 6). This result suggests that EVP prevents the muscle atrophy caused by sciatic denervation in mice.
3.7. Effect of EVP on Ceramide Level by Disuse Muscle Atrophy in Mice
We confirmed the relation of ceramide in sciatic denervation induced muscle atrophy. According to another study, it is widely known that the antiapoptotic function of HSP70 is repressed by ceramide as a proapoptotic factor . We found that the amount of ceramide increased in sciatic denervated mice. The ceramide level exhibited an approximately 3.01-fold increase in the GM and SM of sciatic denervated mice. However, the ceramide level was reduced 17.32% and 38.16% in the EVP group (1-2 mg/kg injection) compared to the non-EVP-treated group of sciatic denervated mice (Figure 7).
This study has the objective to identify effects of new natural products in muscle atrophy. It is absolutely necessary for projects with long-term periods in space and for space-related technology. Our findings can also be applied to skeletal muscular diseases such as muscle atrophy, which is closely related to oxidative stress [31–33]. Furthermore, because normal muscle cells and myoblasts are sensitive to oxidative stress, promoting antioxidative protection effects is a useful strategy to prevent oxidative injury or to delay the progress of related diseases .
HSPs regulate the muscular system as intracellular chaperones. HSP70, especially, has a protective effect against various stresses [34–38]. In this study, HSP70 significantly decreased oxidative stress in vitro and in vivo. Additionally, HSP70 increased with exposure to EVP. Ceramide as a proapoptotic factor was increased by microgravity (in vitro) and sciatic denervation (in vivo). However, EVP reduced the amount of endogenous ceramide. Thus, the protective effects of HSP70 are closely linked to apoptosis inhibition.
Recently, several studies suggest that ROS in skeletal muscle contribute to disuse muscle atrophy [39, 40]. In this study, several stressors (intracellular ROS, microgravity, and sciatic denervation) increased SOD1; However, EVP decreased the expression of SOD1 upon oxidative stress in vitro and in vivo. One study suggested that intramuscular injection of the flavonoid quercetin into the GM effectively prevented loss of muscle weight in hindlimb suspension mice . In another study, rats treated with the lipid-soluble antioxidant, vitamin E, showed disuse muscle atrophy improvement of approximately 20% [39, 40].
Microgravity and sciatic denervation both caused skeletal muscle atrophy. EVP showed an antioxidant capacity that can prevent muscle atrophy from various stresses including microgravity, ROS, and oxidative stress. Systematic studies of biological effects and changes in muscle atrophy via microgravity and disuse have not been completed. Our study suggests a new effect mechanism and a method for treating the muscle atrophy caused by microgravity-induced oxidative stress. Muscle atrophy is also an issue in aging societies because it is a common problem for bed-ridden patients . Using natural products, we aim to find new therapeutic agents for muscle atrophy, which can contribute to improved space technology competitiveness as well as medical advances.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
The authors thank MJ Ko, SW Kim, YL Byeon, JW Yang, and YC Lim students (2012 R&E program, Kwangwon Science High School, South Korea) for useful support. This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2010-00757) and was supported by the Korea-Japan Basic Scientific Cooperation Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (NRF-2012K2A2A4016850) and was supported by Leading Space Core Technology Development Program through the National Research Foundation of Korea (NRF) funded by the by the Ministry of Science, ICT and Future Planning (2011-0030888).
- F. W. Booth, “Effect of limb immobilization on skeletal muscle,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 52, no. 5, pp. 1113–1118, 1982.
- J. Wanagat, N. Ahmadieh, J. H. Bielas, N. G. Ericson, and H. van Remmen, “Skeletal muscle mitochondrial DNA deletions are not increased in CuZn-superoxide dismutase deficient mice,” Experimental Gerontology, vol. 61, pp. 15–19, 2015.
- Y.-P. Li, Y. Chen, A. S. Li, and M. B. Reid, “Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes,” The American Journal of Physiology—Cell Physiology, vol. 285, no. 4, pp. C806–C812, 2003.
- J. Huard, B. Cao, and Z. Qu-Petersen, “Muscle-derived stem cells: potential for muscle regeneration,” Birth Defects Research Part C: Embryo Today: Reviews, vol. 69, no. 3, pp. 230–237, 2003.
- A. Maillet, B. Beaufrere, P. Di Nardo, M. Eli, and C. Pichard, “Weightlessness as an accelerated model of nutritional disturbances,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 4, no. 4, pp. 301–306, 2001.
- T. P. Stein, “Space flight and oxidative stress,” Nutrition, vol. 18, no. 10, pp. 867–871, 2002.
- P. Chowdhury, M. Soulsby, and K. Kim, “L-carnitine influence on oxidative stress induced by hind limb unloading in adult rats,” Aviation Space and Environmental Medicine, vol. 78, no. 6, pp. 554–556, 2007.
- D. I. I. Hemdan, K. Hirasaka, R. Nakao et al., “Polyphenols prevent clinorotation-induced expression of atrogenes in mouse C2C12 skeletal myotubes,” The Journal of Medical Investigation, vol. 56, no. 1-2, pp. 26–32, 2009.
- C.-Y. Kang, L. Zou, M. Yuan et al., “Impact of simulated microgravity on microvascular endothelial cell apoptosis,” European Journal of Applied Physiology, vol. 111, no. 9, pp. 2131–2138, 2011.
- A. J. Caplan, A. K. Mandal, and M. A. Theodoraki, “Molecular chaperones and protein kinase quality control,” Trends in Cell Biology, vol. 17, no. 2, pp. 87–92, 2007.
- K. C. Kregel, “Invited review: heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance,” Journal of Applied Physiology, vol. 92, no. 5, pp. 2177–2186, 2002.
- Y. Xu, G. Zheng, S. Dong, G. Liu, and X. Yu, “Molecular cloning, characterization and expression analysis of HSP60, HSP70 and HSP90 in the golden apple snail, Pomacea canaliculata,” Fish & Shellfish Immunology, vol. 41, no. 2, pp. 643–653, 2014.
- I. J. Benjamin and D. R. McMillan, “Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease,” Circulation Research, vol. 83, no. 2, pp. 117–132, 1998.
- R. Arya, M. Mallik, and S. C. Lakhotia, “Heat shock genes—integrating cell survival and death,” Journal of Biosciences, vol. 32, no. 3, pp. 595–610, 2007.
- N. K. Oksala, F. G. Ekmekçi, E. Özsoy et al., “Natural thermal adaptation increases heat shock protein levels and decreases oxidative stress,” Redox Biology, vol. 3, pp. 25–28, 2014.
- I. G. Bryndina, M. N. Shalagina, S. V. Ovechkin, and N. G. Ovchinina, “Sphingolipids in skeletal muscles of C57B1/6 mice after short-term simulated microgravity,” Rossiĭskii fiziologicheskiĭ zhurnal imeni I.M. Sechenova, vol. 100, no. 11, pp. 1280–1286, 2014.
- T. Kondo, T. Matsuda, M. Tashima et al., “Suppression of heat shock protein-70 by ceramide in heat shock-induced HL-60 cell apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 12, pp. 8872–8879, 2000.
- R. N. Kolesnick, A. Haimovitz-Friedman, and Z. Fuks, “The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation,” Biochemistry and Cell Biology, vol. 72, no. 11-12, pp. 471–474, 1994.
- Z. Yang, M. Costanzo, D. W. Golde, and R. N. Kolesnick, “Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells,” The Journal of Biological Chemistry, vol. 268, no. 27, pp. 20520–20523, 1993.
- T. A. Bird, J. M. Kyriakis, L. Tyshler, M. Gayle, A. Milne, and G. D. Virca, “Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase,” The Journal of Biological Chemistry, vol. 269, no. 50, pp. 31836–31844, 1994.
- J. G. Reyes, I. G. Robayna, P. S. Delgado et al., “c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells,” The Journal of Biological Chemistry, vol. 271, no. 35, pp. 21375–21380, 1996.
- R. T. Dobrowsky, C. Kamibayashi, M. C. Mumby, and Y. A. Hannun, “Ceramide activates heterotrimeric protein phosphatase 2A,” The Journal of Biological Chemistry, vol. 268, no. 21, pp. 15523–15530, 1993.
- B. Sabirzhanov, B. A. Stoica, M. Hanscom, C.-S. Piao, and A. I. Faden, “Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis,” Journal of Neurochemistry, vol. 123, no. 4, pp. 542–554, 2012.
- S. K. Powers, “Can antioxidants protect against disuse muscle atrophy?” Sports Medicine, vol. 44, no. S2, pp. 155–165, 2014.
- S. Granica, M. E. Czerwińska, J. P. Piwowarski, M. Ziaja, and A. K. Kiss, “Chemical composition, antioxidative and anti-inflammatory activity of extracts prepared from aerial parts of Oenothera biennis L. and Oenothera paradoxa Hudziok obtained after seeds cultivation,” Journal of Agricultural and Food Chemistry, vol. 61, no. 4, pp. 801–810, 2013.
- U. Lewandowska, K. Szewczyk, K. Owczarek et al., “Flavanols from evening primrose (Oenothera paradoxa) defatted seeds inhibit prostate cells invasiveness and cause changes in Bcl-2/Bax mRNA ratio,” Journal of Agricultural and Food Chemistry, vol. 61, no. 12, pp. 2987–2998, 2013.
- D. A. M. Mesland, “Possible actions of gravity on the cellular machinery,” Advances in Space Research, vol. 12, no. 1, pp. 15–25, 1992.
- S. Lee, Y.-S. Lee, K.-M. Choi et al., “Quantitative analysis of sphingomyelin by high-performance liquid chromatography after enzymatic hydrolysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 396218, 9 pages, 2012.
- Y. A. Hannun, “Functions of ceramide in coordinating cellular responses to stress,” Science, vol. 274, no. 5294, pp. 1855–1859, 1996.
- L. M. Obeid, C. M. Linardic, L. A. Karolak, and Y. A. Hannun, “Programmed cell death induced by ceramide,” Science, vol. 259, no. 5102, pp. 1769–1771, 1993.
- M. C. Rodriguez and M. A. Tarnopolsky, “Patients with dystrophinopathy show evidence of increased oxidative stress,” Free Radical Biology and Medicine, vol. 34, no. 9, pp. 1217–1220, 2003.
- J. W. Haycock, S. Mac Neil, P. Jones, J. B. Harris, and D. Mantle, “Oxidative damage to muscle protein in Duchenne muscular dystrophy,” NeuroReport, vol. 8, no. 1, pp. 357–361, 1997.
- J. W. Haycock, S. Mac Neil, and D. Mantle, “Differential protein oxidation in Duchenne and Becker muscular dystrophy,” NeuroReport, vol. 9, no. 10, pp. 2201–2207, 1998.
- J. Q. Huang, Y. Y. Jiang, C. Xiao, F. Z. Ren, and X. G. Lei, “Selenoproteins protect against avian nutritional muscular dystrophy by metabolizing peroxides and regulating redox/apoptotic signaling,” Free Radical Biology and Medicine, vol. 15, pp. 40–44, 2015.
- A. M. Leung, M. J. Redlak, and T. A. Miller, “Role of heat shock proteins in oxygen radical-induced gastric apoptosis,” Journal of Surgical Research, vol. 193, no. 1, pp. 135–144, 2015.
- M. Jäättelä, D. Wissing, P. A. Bauer, and G. C. Li, “Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity,” The EMBO Journal, vol. 11, no. 10, pp. 3507–3512, 1992.
- M. M. Simon, A. Reikerstorfer, A. Schwarz et al., “Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release,” Journal of Clinical Investigation, vol. 95, no. 3, pp. 926–933, 1995.
- A. Samali and T. G. Cotter, “Heat shock proteins increase resistance to apoptosis,” Experimental Cell Research, vol. 223, no. 1, pp. 163–170, 1996.
- H. Kondo, M. Miura, and Y. Itokawa, “Antioxidant enzyme systems in skeletal muscle atrophied by immobilization,” Pflügers Archiv European Journal of Physiology, vol. 422, no. 4, pp. 404–406, 1993.
- H. Kondo, I. Nakagaki, S. Sasaki, S. Hori, and Y. Itokawa, “Mechanism of oxidative stress in skeletal muscle atrophied by immobilization,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 265, no. 6, part 1, pp. E839–E844, 1993.
- R. Mukai, R. Nakao, H. Yamamoto, T. Nikawa, E. Takeda, and J. Terao, “Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice,” Journal of Natural Products, vol. 73, no. 10, pp. 1708–1710, 2010.
- K. L. English and D. Paddon-Jones, “Protecting muscle mass and function in older adults during bed rest,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 1, pp. 34–39, 2010.
Copyright © 2015 Yong-Hyeon Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.